Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Objectives. To observe changes in blood glycemic variations and oxidative stress level before and after dapagliflozin treatment in patients with newly diagnosed T2DM. Methods. This was a randomized, double-blind, placebo-controlled, phase 3 trial. A total of 28 patients with newly diagnosed T2DM wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Feng-fei Li, Gu Gao, Qian Li, Hong-hong Zhu, Xiao-fei Su, Jin-dan Wu, Lei Ye, Jian-hua Ma
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2016/5347262
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes
by: Bing-li Liu, et al.
Published: (2018-01-01)

Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
by: Feng-fei Li, et al.
Published: (2017-01-01)

Epidemiological Pattern of Newly Diagnosed Children with Type 1 Diabetes Mellitus, Taif, Saudi Arabia
by: Naglaa Mohamed Kamal Alanani, et al.
Published: (2013-01-01)

Retracted: Epidemiological Pattern of Newly Diagnosed Children with Type 1 Diabetes Mellitus, Taif, Saudi Arabia
by: The Scientific World Journal
Published: (2016-01-01)

Initial Treatment Modalities in Patients with Newly Diagnosed Primary Lung Cancer in Japan
by: Qingqing Hu, et al.
Published: (2025-01-01)

Atypical Distribution of Inflammation in Newly Diagnosed Ulcerative Colitis is not Rare
by: Sang Hyoung Park, et al.
Published: (2014-01-01)

The Gut Microbiota in Women Suffering from Gestational Diabetes Mellitus with the Failure of Glycemic Control by Lifestyle Modification
by: Guangyong Ye, et al.
Published: (2019-01-01)

Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus
by: Soumitra Ray, et al.
Published: (2024-04-01)

The Coincidence of Newly Diagnosed Type 1 Diabetes Mellitus with IgM Antibody Positivity to Enteroviruses and Respiratory Tract Viruses
by: Murat Karaoglan, et al.
Published: (2018-01-01)

Association between dietary patterns and glycemic control in type II diabetes mellitus patients
by: Ye Qiang, et al.
Published: (2025-02-01)

Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China
by: Hao Zhaohu, et al.
Published: (2022-01-01)

A meta-analysis of the association between preoperative magnetic resonance imaging and surgical outcomes in newly diagnosed breast cancer
by: Li-Li Xie, et al.
Published: (2021-04-01)

Thalamic Abscess in a Newly Diagnosed Diabetic Patient
by: Kenneth A. Swanson, et al.
Published: (2019-01-01)

Hypercalcemia in Patients with Newly Diagnosed Tuberculosis in Abuja, Nigeria
by: EA Dosumu, et al.
Published: (2006-01-01)

Expression of atherosclerosis-associated genes in peripheral blood of drug-naïve hypertensive subjects with newly-diagnosed type 2 diabetes mellitus
by: Nikolay Stoynev, et al.
Published: (2025-02-01)

Efficacy and prognosis of dapagliflozin in the treatment of patients with acute myocardial infarction complicated with type 2 diabetes in Xining area
by: Jinping Chai, et al.
Published: (2025-02-01)

The Relation between Serum Uric Acid and HbA1c Is Dependent upon Hyperinsulinemia in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
by: Yuliang Cui, et al.
Published: (2016-01-01)

Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease
by: Yi Yin, et al.
Published: (2022-01-01)

Pseudomonas luteola Bacteremia in Newly Diagnosed Systemic Lupus Erythematosus
by: Mazin Barry
Published: (2021-01-01)

Clinical and Radiological Findings in Patients with Newly Diagnosed Graves’ Ophthalmopathy
by: Yakup Cevik, et al.
Published: (2021-01-01)

Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis
by: Vijay Jaimni, et al.
Published: (2021-01-01)

Prevalence of Screening in Patients Newly Diagnosed with Colorectal Cancer in Ontario
by: Chelsea Taylor, et al.
Published: (2007-01-01)

Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India
by: Thomas Alexander, et al.
Published: (2025-01-01)

The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes
by: Jing Ma, et al.
Published: (2016-01-01)

Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
by: Erik Håkansson, et al.
Published: (2021-01-01)

Diabetes Treatment with Dapagliflozin and Its Combinations: Insights from Clinical Practice
by: Akshay Bafna, et al.
Published: (2024-04-01)

Diabetes Mellitus and HIV Infection among Newly Diagnosed Pulmonary Tuberculosis Patients in the North West Region of Cameroon: A Cross-Sectional Study
by: Leonard Fonkeng Sama, et al.
Published: (2023-01-01)

Assessment of Atrial Conduction Times in Patients with Newly Diagnosed Parkinson’s Disease
by: Yiğit Çanga, et al.
Published: (2018-01-01)

Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
by: Nergiz Bayrakci, et al.
Published: (2022-01-01)

In Vitro Dissolution Profile of Dapagliflozin: Development, Method Validation, and Analysis of Commercial Tablets
by: Rafaela Zielinski Cavalheiro de Meira, et al.
Published: (2017-01-01)

Glycemic Profile and Clinical Treatment in Patients with Diabetes Mellitus-Tuberculosis: An Update Scoping Review
by: Rissaadah S, et al.
Published: (2025-02-01)

Effect Of Vitamin D Supplements In Improving Glycemic Control In Type 2 Diabetes Mellitus
by: Yusra Javaid, et al.
Published: (2024-06-01)

Epidemiological Characteristics and Trends in the Incidence of Newly Diagnosed Pulmonary Tuberculosis in China from 2016 to 2022
by: Caihong Xu, et al.
Published: (2025-01-01)

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
by: Manisha Bhutani, et al.
Published: (2025-02-01)

Bone health in newly diagnosed female breast cancer patients in China: a cross-sectional study
by: Juan Wu, et al.
Published: (2025-02-01)

The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/− Mice
by: Weiling Leng, et al.
Published: (2016-01-01)

Atypical Radiographic Presentation of Cryptococcus Pneumonia in a Newly Diagnosed HIV Patient
by: Arthur Cacacho, et al.
Published: (2019-01-01)

The Fatty Acid Profile in Patients with Newly Diagnosed Diabetes: Why It Could Be Unsuspected
by: C. Castro-Correia, et al.
Published: (2017-01-01)

Incidence of Severe Pain in Newly Diagnosed Ambulatory Patients with Stage IV Cancer
by: Thomas Isaac, et al.
Published: (2012-01-01)

Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma
by: Benjamin A. Derman, et al.
Published: (2018-01-01)